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Abstract
Background/Aims—The importance of epigenetic changes in etiology and pathogenesis of
disease has been increasingly recognized. However, the role of epigenetic alterations in the genesis
of hepatic steatosis and cause of individual susceptibilities to this pathological state are largely
unknown.
Methods—Male inbred C57BL/6J and DBA/2J mice were fed a lipogenic methyl-deficient diet
(MDD) that causes liver injury similar to human nonalcoholic steatohepatitis (NASH) for 6, 12, or
18 weeks, and the status of global and repetitive elements cytosine methylation, histone
modifications, and expression of proteins responsible for those epigenetic modifications in livers
was determined.
Results—The development of hepatic steatosis in inbred C57BL/6J and DBA/2J mice was
accompanied by prominent epigenetic abnormalities. This was evidenced by pronounced loss of
genomic and repetitive sequences cytosine methylation, especially at major and minor satellites,
accompanied by the increased levels of repeat-associated transcripts, aberrant histone modifications,
and alterations in expression of the maintenance DNA methyltransferase 1 (DNMT1) and de novo
DNMT3A proteins in the livers of both mouse strains. However, the DBA/2J mice, which were
characterized by initially lower degree of methylation of repetitive elements and lower extent of
histone H3 lysine 9 (H3K9) and H3 lysine 27 (H3K27) trimethylation in the normal livers, as
compared to those in the C57BL/6J mice, developed more prominent NASH-specific
pathomorphological changes.
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Conclusions—These results mechanistically link epigenetic alterations to the pathogenesis of
hepatic steatosis and strongly suggest that differences in the cellular epigenetic status may be a
predetermining factor to individual susceptibilities to hepatic steatosis.
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1. Introduction
Current trends in biomedical research are moving toward elucidating the molecular
mechanisms, cellular pathways, networks, and processes that underlie the disease
development. Specifically, during recent years much effort has been devoted to uncover the
fundamental mechanisms associated with individual susceptibilities to any given pathological
state, including nonalcoholic steatohepatitis (NASH), a progressive form of nonalcoholic fatty
liver disease, characterized by lipid accumulation in the liver, inflammation, hepatocellular
damage and fibrosis [1,2]. This has a great significance for identifying vulnerable
subpopulations and for establishing new prevention strategies [3].
In the post-genomic era, mice have become the predominant experimental animal model for
many aspects of biomedical research because they share many physiological, anatomical, and
metabolic properties with humans [4,5]. Furthermore, genetically defined inbred mice
represent a broad genetic diversity similar to the human population, which allows the
investigation of important aspects of individual susceptibilities to disease development [6].
Indeed, it has been demonstrated that inbred strains of mice differ greatly in their susceptibility
to NASH [6,7]. Likewise, genetic factors greatly influence individual susceptibility to NASH
[2] in humans. It is widely believed that genetic variations that underlie disease susceptibility
have a great impact on phenotype through disruption of various metabolic pathways [4,8] and
different susceptibility to NASH may be associated primarily with differences in the
genetically-predetermined phenotype [7].
During the past decade, the role of epigenetic mechanisms in etiology and pathogenesis of
disease has been increasingly recognized [9]. These epigenetic mechanisms, particularly
methylation of DNA and modifications of the histones’ amino-terminal tails, are essential for
the proper maintenance of cellular homeostasis. The epigenetic status in normal cells is
accurately maintained and balanced, and disruption of this balance leads to the development
of a wide range of human pathologies [9]. However, the role of epigenetic alterations in the
genesis of hepatic steatosis and the cause of the individual-to-individual variation in sensitivity
to NASH are largely unknown. The results of several studies have demonstrated that mouse
inter-strain differences in sensitivity to liver injury and liver carcinogenesis induced by
phenobarbital are inversely related to the capacity to maintain normal patterns of hepatic DNA
methylation [10]. Likewise, resistance to 2-acetylaminofluorene-induced liver carcinogenesis
in female Sprague-Dawley rats is associated with a greater level of histone H3K9 and histone
H4K20 trimethylation in the livers when compared to sensitive male rats [11]. These findings
suggest that differences in the cellular epigenetic status may be a predetermining factor to
different susceptibilities to hepatic steatosis.
In light of these considerations, the present study was undertaken to: 1) define the role of
epigenetic alterations, such as DNA methylation and histone modifications, in the genesis of
hepatic steatosis in mice, a pathological state that is similar to human NASH; and 2) determine
whether or not strain-specific susceptibility of mice to hepatic steatosis is associated with
differences in individual epigenetic phenotypes.
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2. Materials and methods
2.1. Animals, diets, and experimental design
In the initial experiment, we determined the epigenetic profile in the male BALB/CJ, C3H/
HeJ, A/J, AKR/J, C57BL/6J, and DBA/2J mice livers (Jackson Laboratory, Bar Harbor, ME).
For the main study, male C57BL/6J and DBA/2J mice (Jackson Laboratory) were housed in
sterilized cages in a temperature-controlled (24°C) room with a 12 hour light/dark cycle, and
given ad libitum access to purified water and NIH-31 pelleted diet (Purina Mills, Richmond,
IN). At eight weeks of age, the mice from each strain were allocated randomly into two groups,
one control and one experimental. The mice from the experimental groups were maintained
on a low methionine (0.18%) diet, lacking in choline and folic acid (Dyets, Inc, Bethlechem,
PA) for 18 weeks. The mice from the control groups received diet supplemented with 0.4%
methionine, 0.3% choline bitartrate, and 2 mg/kg folic acid. Diets were stored at 4°C and given
ad libitum, with twice a week replacement. Five experimental and five control mice were
sacrificed at 6,12, and 18 weeks after diet initiation. All animal experimental procedures were
carried out in accordance with the animal study protocol approved by the National Center for
Toxicological Research Animal Care and Use Committee.
2.2. Necropsy, tissue processing, and histopathology
At the completion of the designated experimental intervals, mice were euthanized humanely
using CO2. The livers were excised and a slice of the medial lobe was fixed in 10% neutral
buffered formalin for 48 hours for histopathologic examination. The remaining liver was frozen
immediately in liquid nitrogen and stored at −80°C for subsequent analyses. The formalin-
fixed liver slices were further processed and embedded in Tissue Prep II paraffin, sectioned at
4 microns, mounted on a glass slide, and stained with hematoxylin and eosin, and coverslipped.
The liver sections were evaluated for steatosis, hepatocellular degeneration, inflammation,
hepatocellular karyocytomegaly and oval cell proliferation, and scored using a severity score
system for each of the morphologic parameters as follows: grade 0, none present; grade 1,
minimal; grade 2, mild; grade 3, moderate; grade 4, marked; and grade 5, severe changes.
2.3. Determination of hepatic triglycerides content
Hepatic triglycerides were extracted by homogenizing 20 mg of liver tissue in 500 µl of
isopropyl alcohol. Next, 4 µl of extract was used for subsequent analysis. The level of
triglycerides was determined by using Wako L-Type TG-M Assay Kit (Wako Diagnostic,
Richmond, VA) according to the manufacturer's instruction.
2.4. Determination of global DNA methylation by cytosine extension assay
The extent of global DNA methylation was evaluated with a cytosine extension assay as
described in Pogribny et al. [12].
2.5. Determination of hepatic methionine, S-adenosyl-L-methionine (SAM), and S-adenosyl-
L-homocysteine (SAH) content
The determination of methionine, SAM, and SAH content in liver tissue extracts was performed
by a HPLC method with coulometric electrochemical detection as previously described [13].
2.6. Quantitative PCR (qPCR) methylation analysis of DNA repetitive sequences
The methylation analysis of repetitive elements of mouse genome, including major and minor
satellites, intracesternal A particle (IAP), long interspersed elements (LINEs), and short
interspersed elements (SINEs), was determined by methylation-sensitive McrBC-qPCR assay
as described previously [14]. Genomic DNA (1µg) was digested overnight with the
methylation-specific restriction enzyme McrBC (New England Biolabs, Ipswich, MA) and
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then analyzed by qPCR with primers described in Martens et al. [13]. Two-step qPCR was
performed using a SYBR® GreenER™ SuperMix (Invitrogen, Carlsbad, CA) for iCycler (Bio-
Rad, Hercules, CA) with 40 cycles of 45 sec at 95°C and 90 sec at 58°C. After the final cycle,
melting curve analysis of all samples was conducted within the range of 55–95°C. All reactions
were run in triplicate. The threshold cycle (Ct) is defined as the fractional cycle number that
passes the fixed threshold. The Ct values for each repetitive element were converted into
absolute amount of input DNA using the absolute standard curve method. An increased amount
of input DNA after digestion with McrBC is indicative of hypomethylation, whereas a
decreased amount of input DNA is indicative of hypermethylation.
2.7. Quantitative reverse transcription-PCR (qRT-PCR)
Total RNAs were isolated from the liver tissue using TRI Reagent (Ambion, Austin, TX)
according to the manufacturer's instruction. The levels of repeat-associated and carnitine
palmitoyltransferase 1a (Cpt1a) gene transcripts were determined by qRT-PCR as described
previously [7,14]. Relative quantification of gene expression was performed by using
glyceraldehyde-3-phosphate dehydrogenase (Gapdh) as an internal control. The 2−ΔΔCt
method was used for calculating the relative amount of the target RNA [15]. The qRT-PCR
was performed at least three times and always included a no-template sample as a negative
control.
2.8. Western immunoblot analysis of histone modifications
The levels of histone macroH2A and status of H3K9me3, H3K27me3, and histone H4K20me3
in mouse livers were determined by Western immunoblot analysis as described previously
[16].
2.9. Western immunoblot analysis of protein expression
The liver protein levels of DNMT1, DNMT3A, methyl-CpG-binding protein MeCP2, histone
lysine methyltransferases (KMT) Suv39h1, Suv4-20h2, and RIZ1, and β-actin were determined
by Western immunoblot analysis as described previously [16].
2.10. Statistical analysis
Results are presented as mean ± S.D and were assessed by two-way analysis of variance
(ANOVA) using treatment and weeks as fixed factors, or one-way ANOVA using treatment
as the fixed factor. P-values < 0.05 were considered significant.
3. Results
3.1. Epigenetic profiling reveals strain-specific differences in the livers of inbred mice
Analysis of the epigenetic status in the livers of BALB/CJ, C3H/HeJ, A/J, AKR/J, C57BL/6J,
and DBA/2J mice revealed the substantial strain-to-strain differences in the degree of cytosine
methylation and histone modification patterns (Table 1). The most prominent strain-specific
epigenetic differences were detected in DBA/2J mice compared to A/J, AKR/J, BALB/CJ,
C3H/HeJ, and C57BL/6J strains. Interestingly, the epigenetic profile in the normal livers of
DBA/2J mice was similar to that detected in livers of animals that had been exposed to non-
genotoxic liver carcinogens peroxisome proliferator WY-14,643 or a methyl-deficient diet
[17,18]. Based on these criteria, for the main study we selected DBA/2J mice as strain that may
be sensitive to the development of hepatic steatosis. From the three potentially resistant strains,
BALB/CJ, C3H/HeJ, and C57BL/6J, that are characterized by a similar liver epigenetic
phenotype, for our main study we selected C57BL/6J mice based on evidence that this strain
is characterized by a greater extent of methylation of highly active IAP elements (Table 1).
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3.2. Histopathology of liver of C57BL/6J and DBA/2J mice fed a MDD
The administration of a MDD to C57BL/6J and DBA/2J mice for 18 weeks resulted in fatty
changes in the liver parenchyma (Figure 1). The presence of steatosis in the livers of mice fed
a MDD was also evidenced by a pronounced increase in the hepatic triglyceride concentrations
in both mouse strains; however, the level of triglycerides in DBA/2J mice was significantly
greater than in C57BL/6J mice (Figure 1B). Additionally, livers of mice fed a MDD were
characterized by significant hepatocellular degeneration and necrosis, liver inflammation,
karyocytomegaly, enlarged hepatocytes with enlarged nuclei and oval cell proliferation (Figure
1A). These liver effects were progressive with duration time on diet being most severe overall
in the DBA/2J mice fed a MDD for 18 weeks was substantially greater compared to those
parameters in C57BL/6J mice (Table 2).
3.3. Effects of a MDD on the DNA methylation in the livers of C57 BL/6J and DBA/2J mice
In the livers of control C57BL/6J and DBA/2J mice, the extent of DNA methylation did not
change over the 18 week period (Figure 2). In the livers of mice fed a MDD, DNA became
progressively demethylated, as evidenced from an increase in incorporation of [3H]dCTP into
HpaII-digested DNA. However, the magnitude of DNA hypomethylation in the livers of
methyl-deficient DBA/2J mice was more pronounced compared to the C57BL/6J strain, with
the difference between strains being significant after 18 weeks on diet (Figure 2). Interestingly,
the more pronounced loss of DNA methylation in the livers of DBA/2J mice cannot be
explained by a difference in hepatic methyl-donor metabolism (Figure 3). This was evidenced
by greater levels of methionine and SAM in the livers of control DBA/2J mice as compared to
age-matched C57BL/6J mice (Figures 3A and 3B), and by a greater accumulation of SAH, a
potent inhibitor of all cellular methylation reactions, in the livers of methyl-deficient C57BL/
6J mice than in DBA/2J mice (Figure 3C). Additionally, we determined the effect of methyl-
deficiency on the extent of cytosine methylation at GC-rich DNA domains. For this purpose,
DNA was isolated from control and methyl-deficient mice after 18 weeks of deficiency was
digested with AscI, BssHII, or NarI methylation-sensitive restriction endonucleases, whose
recognition sequences occur predominantly at GC-rich regions. Similarly to global DNA
hypomethylation, feeding a MDD resulted in substantial loss of cytosine methylation at GC-
rich domains, especially in the livers of DBA/2J mice (Supplementary Figure 1).
3.4. Effects of a MDD on the extent of methylation of repetitive DNA elements
One of the primary functions of DNA methylation in normal cells is safeguarding the genome
by silencing repetitive DNA elements [19], and global DNA hypomethylation is generally
reflective of decreased methylation in those repetitive sequences [20]. In view of this, we
measured the methylation status of major and minor satellites, LINE1, SINEs, and IAP
elements that compose the majority of the mouse genome. Figure 4 shows the substantial loss
of cytosine methylation at major and minor satellites, LINE1, SINEs, and IAP elements in the
livers of both mouse strains after 18 weeks of methyl deficiency. More importantly, feeding a
MDD caused a greater loss of cytosine methylation of all analyzed repetitive elements,
especially major and minor satellites, in DBA/2J mice compared to C57BL/6J mice.
3.5. Effects of a MDD on expression of repeat-associated transcripts
Since loss of cytosine methylation at repetitive elements could be linked to the increased
expression of repeat-associated transcripts [21,22], we determined the levels of major-, minor-,
LINE-, SINE-, and IAP-transcripts in the livers of C57BL/6J and DBA/2J mice fed a methyl-
deficient diet. The expression of all analyzed repetitive elements in the livers of C57BL/6J
mice, fed a MDD did not change over the 18 week period (data not shown); likewise, the
expression of LINE, SINE, and IAP elements in the livers of DBA/2J mice fed a MDD did not
change over the 18 week period (data not shown). In contrast, the levels of the major- and,
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especially, the minor-associated transcripts in the livers of DBA/2J mice fed a MDD increased
after 18 weeks of exposure (Figure 5A and 5B). Interestingly, at that time, the level of minor-
associated transcripts in the livers of DBA/2J mice fed a MDD was 3.1 times greater than in
the livers of methyl-deficient C57BL/6J mice.
An opposite trend was observed for changes in expression of the Cpt1a gene in the livers of
C57BL/6J and DBA/2J mice (Figure 5C). Feeding a MDD resulted in down-regulation of the
Cpt1a gene in the livers of both mouse strains; however, the loss of Cpt1a expression in the
livers of methyl-deficient DBA/2J mice was 2.4 times greater than that observed in the C57BL/
6J mice.
3.6. Effects of a MDD on histone modifications
The results of our previous studies demonstrated that feeding rats a MDD, in addition to the
DNA methylation changes, was associated with profound alterations in the histone
modification patterns [18]. In view of this, we studied the effect of MDD on the status of histone
macroH2A and extent of histone H3K9, H3H27, H4K20 trimethylation in the livers of C57BL/
6J and DBA/2J mice. In the livers of C57BL/6J and DBA/2J mice fed a MDD, the level of
histone macroH2A increased considerably, especially in the livers of DBA/2J mice, with the
difference between strains being significant after 12 and 18 weeks of feeding (Figure 6A). At
those times, the level of histone macroH2A in the livers of DBA/2J mice was, respectively,
2.2 and 3.1 times greater than in the age-matched control mice, and 1.3 and 1.5 times,
respectively, greater than in the methyl-deficient C57BL/6J mice. Feeding a MDD resulted in
an increase of histone H3K9me3 levels in the livers of C57BL/6J and DBA/2J mice (Figure
6B), did not affect the trimethylation status of H3K27 in the livers of C57BL/6J mice, but
caused a slight loss of H3K27 trimethylation in the livers of DBA/2J mice (Figure 6C), and
resulted in a significant similar loss of H4K20me3 in both mouse strains (Figure 6D).
3.7. Effects of a MDD on expression of proteins responsible for DNA and histone lysine
methylation
The observed changes in the levels of DNA and histone lysine methylation in the livers of
methyl-deficient mice prompted us to investigate the expression of proteins that are responsible
for these epigenetic modifications. Figure 7 shows that feeding C57BL/6J and DBA/2J mice
a MDD resulted in significant decrease in the levels of DNMT1 protein, the main DNA
methyltransferase that is required for the accurate maintenance of the DNA methylation
patterns in somatic cells, in the livers of both mouse strains. Interestingly, the protein levels of
de novo DNA methyltransferase DNMT3A increased substantially in the livers of C57BL/6J
methyl-deficient mice, but not in DBA/2J mice. Feeding a MDD did not affect the expression
of methyl-CpG-binding protein MeCP2 and KMT Suv39h1 in both strains of mice, but caused
a slight decrease in the level of Suv4-20h2 protein in the livers of DBA/2J mice (Figure 6).
More importantly, a MDD diet induced a significant decrease of RIZ1, a critical target in
methyl-deficient hepatocarcinogenesis [23].
4. Discussion
The results of the present study demonstrate that feeding of C57BL/6J and DBA/2J mice a
MDD for 18 weeks resulted in the progressive accumulation of morphological changes in the
livers similar to human NASH (Figure 1, Table 2). These pathomorphological changes were
accompanied by prominent deregulation of epigenetic mechanisms, evidenced by the loss of
genomic and repetitive sequences methylation, aberrant histone modifications and alterations
in expression of proteins responsible for DNA and histone lysine methylation. More
importantly, the pathological and epigenetic changes induced by methyl deficiency were more
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prominent in the livers of DBA/2J mice than in the C57BL/6J mice; however, they were not
associated with interstrain differences in hepatic methionine metabolism (Figure 3).
The present study shows that administration of a MDD to C57BL/6J and DBA/2J mice resulted
in pronounced demethylation of genome and repetitive elements (Figure 2 and Figure 4)
accompanied by decreased expression of the maintenance DNMT1 and KMT RIZ1 (Figure 7)
and loss of histone H3K27 and H4K20 trimethylation (Figures 6C and 6D). This may
compromise integrity of genome via heterochromatin reorganization. Specifically, a low level
of DNA methylation in combination with a high content of histone macroH2A and the
decreased levels of H3K9 and H4K20 trimethylation, known marks of constitutive
heterochromatin, is associated with formation of significantly altered chromatin configuration
[24,25]. We detected similar changes in the livers of both mouse strains fed a methyl-deficient
diet, with the magnitude being greater in DBA/2J mice. One of the possible explanations of
the greater degree of demethylation of genomic DNA and, particularly, repetitive elements in
the livers of methyl-deficient DBA2J mice compared to methyl-deficient C57BL/6J mice may
be the differences in DNMTs expression. Both mouse strains fed a MDD were characterized
by the profoundly decreased DNMT1 expression; however, the expression of de novo
methyltransferase DNMT3A was increased only in the livers of C57BL/6J mice (Figure 7). It
is has been shown that cooperativity between DNMT1 and DNMT3a is absolutely required for
the maintenance of the methylation of repetitive elements and DNMT1, by itself, is not capable
of maintaining the repetitive elements methylation [26]. The hypomethylation of repetitive
sequences, especially centromeric minor and pericentromeric major satellites, in the livers of
DBA/2J mice may lead to the induction of centromere abnormalities and chromosome
segregation defects. Indeed, recent findings have demonstrated that DNA hypomethylation
causes a permissive transcriptional activity at the centromere [21] and subsequent accumulation
of small murine minor satellite transcripts that impaired centromeric architecture and function
[27]. Interestingly, the Cpt1a, which encodes the liver isoform of CPT1, an enzyme critical for
the proper function of β-oxidation in liver, is located in centromeric region of mouse
chromosome 19 [28] and human chromosome 11 [29]. The profound accumulation of minor
satellite transcripts associated with their severe demethylation may cause centromeric defects
and compromise the function of the genes located in this chromosomal region. The down-
regulation of Cpt1a gene expression detected in the current (Figure 4) and previous studies
[7] support this suggestion. As has been mentioned above, the impaired β-oxidation of LCFA
is one of the main mechanisms in the pathogenesis of mouse hepatic steatosis and human NASH
[1,6,7,30].
One of the most important features of human NASH and mouse models of hepatic steatosis
induced by a methyl-deficient diet is lipid accumulation in the liver [1,7,30,31]. Several
mechanisms of lipid accumulation in human NASH and in mouse hepatic steatosis, including
increased long-chain fatty acid (LCFA) uptake, increased de novo hepatic LCFA and
triglyceride synthesis, decreased synthesis and secretion of very low density lipoprotein
particles, and decreased mitochondrial β-oxidation have been proposed [1,6,30]. It has been
suggested that the predominant pathogenic mechanism in the induction of hepatic steatosis in
a mouse methyl-deficient model is impaired β-oxidation of LCFA [6,7]. However, the precise
mechanisms by which the methyl-deficient diet leads to the development of hepatic steatosis
and mechanisms of inter-strain differences in susceptibility are unknown [7].
These findings strongly suggest that epigenetic dysregulation is the prominent fundamental
feature of hepatic steatosis in mice fed a methyl-deficient diet. More importantly, the results
of our study indicate that differences in the cellular epigenetic status may be a predetermining
factor to individual susceptibilities to NASH development in humans. This has a great
significance for identification of vulnerable subpopulation to NASH and, considering the
potential reversibility of epigenetic alterations, opens novel prevention approaches to NASH.
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KMT, histone lysine methyltransferase
SAM, S-adenosyl-L-methionine
SAH, S-adenosyl-L-homocysteine
H3K9, H3 lysine 9
H3K27, histone H3 lysine 27
H4K20, histone H4 lysine 20
qRT-PCR, quantitative real-time-PCR
IAP, intracesternal A particle
LINE, long interspersed element
SINE, short interspersed element
ANOVA, analysis of variance
LCFA, long-chain fatty acid
Cpt1, carnitine palmitoyltransferase 1
Gapdh, glyceraldehyde-3-phosphate dehydrogenase.
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Figure 1. Histomorphological changes (A) and triglyceride concentrations (B) in the livers of
C57BL/6J and DBA/2J mice fed a methyl-deficient diet for 18 weeks
(A) Normal liver from a control C57BL/6J (I) and DBA/2J (II) mice. Representative
histopathological changes in the livers of methyl-deficient C57BL/6J (III, IV) and DBA/2J
(IV, VI) mice. Diffuse marked macrovesicular steatosis, grade 4, in C57BL/6J (III) and grade
5 in DBA/2J (IV) mice. Hepatic centrilobular region with typical changes in the livers of
methyl-deficient DBA/2J mice (VI). Depleted (necrotic) hepatocytes replaced by fibrosis (short
arrow), inflammation (arrow heads), and oval cell proliferation (long arrows). Note
megalocytosis (karyocytomegally) of hepatocytes (*). Similar, but milder lesions observed in
the livers of methyl-deficient C57BL/6J mice (V).
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(III) and (IV). Original magnification 50x; (I), (II), (V), and (VI) – Original magnification
200x. c- centrilobular region, p – periportal region, L – lipid vacuole.
The hepatic triglycerides concentrations are presented as mean ± S.D. (n=5) relative to control
at the same time point. a – Significantly different from control at the same time point; b -
significantly different from C57BL/6J mice fed a methyl-deficient diet at the same time point.
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Figure 2. Level of global DNA methylation in the livers of C57BL/6J and DBA/2J mice fed a methyl-
deficient diet for 18 weeks and age-matched control mice
The DNA methylation status in the livers of control mice (gray bars) and mice fed a methyl-
deficient diet (black bars) was assessed using [3H]dCTP extension assay after digestion of
genomic DNA with methylation-sensitive restriction endonuclease HpaII that cleaves CCGG
sequences when internal cytosine residues are unmethylated on both strands. The extent of
[3H]dCTP incorporation is directly proportional to the number of unmethylated CpG sites.
Data are presented as mean ± S.D. (n=5) relative to control at the same time point. a –
Significantly different from control at the same time point; b - significantly different from
C57BL/6J mice fed a methyl-deficient diet at the same time point.
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Figure 3. Levels of methionine (A), SAM (B), SAH (C), and SAM/SAH ratio (D) in the livers of
C57BL/6J and DBA/2J mice fed a methyl-deficient diet for 18 weeks and age-matched control mice
Data is presented as mean ± S.D. (n=5) relative to control at the same time point. a –
Significantly different from control at the same time point; b - significantly different from
C57BL/6J mice fed a methyl-deficient diet at the same time point; c - significantly different
from control C57BL/6J mice.
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Figure 4. Level of DNA methylation of repetitive elements in the livers of C57BL/6J and DBA/2J
mice fed a methyl-deficient diet for 18 weeks and age-matched control mice
The DNA methylation status of major and minor satellites, IAP, LINE, and SINE elements in
the livers of control mice (gray bars) and mice fed a methyl-deficient diet (black bars) was
assessed using the methylation-sensitive McrBC-qPCR assay as detailed in “Materials and
methods”. McrBC is a methylation-specific endonuclease, which, as opposed to methylation-
sensitive restriction enzymes, cleaves DNA containing 5-methylsytosine residues on one or
both strands but will not act on unmethylated DNA. Because of that a greater PCR product
recovery, evidenced by lower Ct value, after pretreatment of DNA with McrBC, is indicative
of hypomethylation. Data is presented as mean ± S.D. (n=5) relative to control at the same time
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point. a – Significantly different from control at the same time point; b - significantly different
from C57BL/6J mice fed a methyl-deficient diet at the same time point; c - significantly
different from control C57BL/6J mice.
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Figure 5. Expression of major- and minor-associated transcripts and Cpt1a gene in the livers of
C57BL/6J and DBA/2J mice fed a methyl-deficient diet for 18 weeks and age-matched control mice
The level of expression of major- and minor-associated transcripts and Cpt1a gene was
measured using the qRT-PCR. The results are presented as fold change of major- and minor-
associated transcripts and Cpt1a gene in the livers of mice fed a methyl-deficient diet (black
bars) relative to control mice (gray bars) at the same time point after normalization to Gapdh
(mean ± S.D., n=5). a – Significantly different from control at the same time point; b -
significantly different from C57BL/6J mice fed a methyl-deficient diet at the same time point.
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Figure 6. Western blot analysis of histone modifications in the livers of C57BL/6J and DBA/2J mice
fed a methyl-deficient diet for 18 weeks and age-matched control mice
Acid extracts of total histones were isolated from the livers of control mice (gray bars) and
mice fed a methyl-deficient diet (black bars), separated by SDS-PAGE, and subjected to
immunoblotting using specific antibodies against histone macroH2A and H3K9me3,
H3K27me3, and histone H4K20me3. Chemifluorescence detection was performed with the
ECF Substrate for Western Blotting (GE Healthcare Biosciences, Piscataway, NJ) and
measured directly by a Storm Imaging System (Molecular Dynamics, Sunnyvale, CA). The
signal intensity was analyzed by ImageQuant software (Molecular Dynamics). These results
were reproduced in two independent experiments. (A) Level of histone macroH2A; (B) Level
of H3K9me3; (C) Level of H3K27me3; (D) Level of H4K20me3.
Data are presented as mean ± S.D. (n=5) relative to control at the same time point.
a - Significantly different from control at the same time point; b - significantly different from
C57BL/6J mice fed a methyl-deficient diet at the same time point; c - significantly different
from control C57BL/6J mice.
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Figure 7. Western blot analysis of proteins responsible for DNA and histone lysine methylation in
the livers of C57BL/6J DBA/2J fed a methyl-deficient diet for 18 weeks and age-matched control
mice
Liver tissue lysates from the livers of control mice (gray bars) and mice fed a methyl-deficient
diet (black bars) were separated by SDS-PAGE and subjected to Western immunoblotting
using specific antibodies against DNMT1, DNMT3A, methyl-CpG-binding protein MeCP2,
and KMTs Suv39h1, Suv4-20h2, and RIZ1. Equal sample loading was confirmed by
immunostaining against β-actin. These results were reproduced in two independent
experiments. Representative Western immunoblot images are shown. The images were
analyzed as described in Figure 5 legend. Data are presented as mean ± S.D. (n=5) relative to
age-matched control mice. Control values at each time point were considered as 100%.
a .Significantly different from the control at the same time point.
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Table 2
Summary of pathomorphological changes in the livers of C57BL/6J and mice fed a methyl-deficient diet for 18




Steatosis 4.8 ± 0.4* 3.8 ± 0.8
Necrosis 3.8 ± 0.4* 2.0 ± 0.7
Inflammation 2.0 ± 0.1 2.4 ± 0.9
Oval cell hyperplasia 2.6 ± 0.5* 1.4 ± 0.5
Karyocytomegaly 2.4 ± 0.6* 1.0 ± 0.1
*
Significantly different from C57BL/6J mice fed a MDD.
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